Navigation Links
WorldHeart Reports an Event of Default Under the Note Issued to Abiomed, Resignation of One of Its Board of Directors, and Results of Shareholder Vote at Its Annual Shareholders' Meeting
Date:5/9/2008

OAKLAND, Calif., May 9 /PRNewswire-FirstCall/ -- (Nasdaq: WHRT, TSX: WHT) Since January 2008, World Heart Corporation (the "Company") has aggressively pursued various financing alternatives to raise additional capital, including through equity financing transactions and corporate collaborations, in order to continue operations. At April 30, 2008, the Company had cash and cash equivalents of approximately $0.5 million and current liabilities of approximately $2.6 million. On May 2, 2008, the Company learned that its potential primary investor may not be able to give its assurance of commitment to allow the Company to access capital to meet current financing needs. This information resulted in the Company making the determination that its available cash would be insufficient to pay the Company's obligations as they become due, which constitutes an event of default under the Company's secured convertible promissory note in the amount of $5.0 million issued on December 11, 2007 to Abiomed, Inc. This event of default under the note results in the outstanding principal balance of the note, together with accrued but unpaid interest and any other amounts owing under the Abiomed note documents, becoming immediately due and payable to Abiomed. The note is secured by security agreements entered into by the Company and the Company's wholly-owned subsidiary, World Heart, Inc. ("WHI"), in favor of Abiomed, that grant a security interest in all of their respective assets. Abiomed could exercise its remedies under law and under the security agreements, including foreclosing on the assets of the Company and WHI. An event of default also permits Abiomed to terminate the clinical and marketing support services agreement.

The Company has an immediate need for additional capital in order to satisfy its obligations and to continue operations. The Company continues to aggressively pursue various financing alternatives but its efforts to raise additional capital have not been
'/>"/>

SOURCE World Heart Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. WorldHeart 10-KSB Audit Report Includes Going Concern Qualification
2. WorldHeart Schedules Teleconference
3. Cardium Reports on First Quarter 2008 Highlights and Financial Results
4. Novavax Reports First Quarter 2008 Financial Results
5. Warner Chilcott Reports Operating Results for the Quarter ended March 31, 2008 and Updates 2008 Full Year Guidance
6. Biodel Inc. Reports Second Quarter Fiscal Year 2008 Financial Results
7. Pharmos Corporation Reports 2008 First Quarter Results
8. Halozyme Therapeutics Reports 2008 First Quarter Financial Results
9. Nuvelo Reports First Quarter 2008 Financial Results and Updated Outlook for 2008
10. Favrille Reports First Quarter 2008 Financial Results
11. Barr Reports First Quarter 2008 GAAP Earnings of $0.21 Per Share; Adjusted Earnings of $0.57 Per Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... Corporation (NASDAQ: NEOG ) announced today that it has ... food testing laboratory based in southwest India ... base for the company,s new operations in India ... was incorporated in 1990, and its business has grown to ... testing for major hotels and restaurants in its home region, ...
(Date:6/1/2015)... (PRWEB) June 01, 2015 Sistemic ... have entered into a commercial collaboration agreement and ... will combine their technologies and work together towards ... regenerative technology. RoosterBio and Sistemic will collaborate on ... to build more precise and relevant characterization panels ...
(Date:6/1/2015)... 2015 Esperance Pharmaceuticals Inc. today reported positive ... EP-100 in ovarian cancer patients resistant to paclitaxel. EP-100 ... destroy cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) ... a wide range of cancers. Results ... EP-100 were presented at the 2015 ASCO Annual ...
(Date:6/1/2015)... , June 1, 2015  Berg, a biopharmaceutical company ... approach, presented clinical research from its trials using its ... and preclinical data on triple negative breast cancer, at ... Society of Clinical Oncology (ASCO), May 29 – June ... BPM 31510 is one of the first cancer ...
Breaking Biology Technology:Neogen acquires India food safety company 2Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 2Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 3Sistemic and RoosterBio Inc Announce Broad Collaboration Agreement to Advance miRNA and Mesenchymal Stem/Stromal Cell (MSC) Regenerative Technology 4Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3
... The Board of,Directors of Shire plc (LSE: SHP, ... announces today that David Mott will,join the Board ... Mr Mott is Chief Executive Officer and ... to in 2000. He joined MedImmune in 1992 ...
... ... Data, VANCOUVER ... a clinical-stage developer of drugs for infectious,diseases will present at the Acumen ... York Palace Hotel in New York,NY on November 5-7, 2007. Jim DeMesa, ...
... Oct. 31 Amedica Corporation,an orthopedic implants company ... the U.S. Food and Drug Administration,has granted 510(k) ... The Valeo(TM) Cervical Plate system combines features aimed ... The,Valeo(TM) Cervical Plate system is intended for anterior ...
Cached Biology Technology:David Mott Appointed Non Executive Director at Shire 2David Mott Appointed Non Executive Director at Shire 3MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3
(Date:5/27/2015)... , May 27, 2015   ... medication safety systems and image documentation solutions ... of comprehensive, technologically-advanced automation solutions, is pleased ... integration. The Codonics® Safe Label System® (SLS), ... in conjunction with the Omnicell Anesthesia Workstation, ...
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... has resulted in a design for high tech polyvalent rescue ... immediately carry up to four patients away for treatment. The ... of four-stretcher support that can be installed in different vehicles. ... adapted to a range of vehicles while offering weight reductions ...
... Scientists at Burnham Institute for Medical Research (Burnham) have ... major role in promoting programmed cell death (apoptosis), helps relay ... invade surrounding tissues. The study was published in the journal ... of scientists, led by Kristiina Vuori, M.D., Ph.D., professor and ...
... reports last week about scuba divers off San Diego being ... raised the ire of University of Rhode Island biologist Brad ... has dived with them several times, he calls the reports ... For years Seibel has heard stories claiming that Humboldt ...
Cached Biology News:High-tech vehicle design boosts emergency rescue capacity 2High-tech vehicle design boosts emergency rescue capacity 3Protein that promotes cancer cell growth identified 2URI researcher sheds light on 'man-eating' squid; finds them timid, non-threatening 2URI researcher sheds light on 'man-eating' squid; finds them timid, non-threatening 3
... Collect eliminates manual data entry by collecting ... any Windows-based application. Collect is extremely ... hours of tedious data entry. An ... scales, pH meters, spectrophotometers, force gauges, digital ...
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
Purified anti-LAT...
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: